Page last updated: 2024-09-03

celastrol and Cancer of the Uterus

celastrol has been researched along with Cancer of the Uterus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Areecheewakul, S; Bi, J; Dai, D; Ebeid, K; Leslie, KK; Li, L; Li, Y; Meng, X; Salem, AK; Thiel, KW; Yang, S; Zhang, J; Zhang, Y	1

Other Studies

1 other study(ies) available for celastrol and Cancer of the Uterus

Article	Year
MTDH/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy. Gynecologic oncology, 2019, Volume: 155, Issue:2 Topics: Animals; Antineoplastic Agents; Cisplatin; Cystadenocarcinoma, Serous; Down-Regulation; Drug Resistance, Neoplasm; Fanconi Anemia Complementation Group D2 Protein; Fanconi Anemia Complementation Group Proteins; Female; Male; Membrane Proteins; Mice, Knockout; Nanoparticles; Pentacyclic Triterpenes; RNA-Binding Proteins; Triterpenes; Uterine Neoplasms	2019

Article

Year

MTDH/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy.

Gynecologic oncology, 2019, Volume: 155, Issue:2

Topics: Animals; Antineoplastic Agents; Cisplatin; Cystadenocarcinoma, Serous; Down-Regulation; Drug Resistance, Neoplasm; Fanconi Anemia Complementation Group D2 Protein; Fanconi Anemia Complementation Group Proteins; Female; Male; Membrane Proteins; Mice, Knockout; Nanoparticles; Pentacyclic Triterpenes; RNA-Binding Proteins; Triterpenes; Uterine Neoplasms

2019